Distinct serum cytokines in AIDS-related skin diseases

Viral Immunology

Volumn 11, Issue 4, 1998, Pages 215-220

  Breuer McHam, Joan N ^a,b   Marshall, Gailen D ^a   Lewis, Dorothy E ^c   Duvic, Madeleine ^a,b,d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Section of Dermatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; NONHUMAN; PROTEIN BLOOD LEVEL; PRURITUS; PSORIASIS; SKIN DISEASE;

EID: 0032410385     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1998.11.215     Document Type: Article

References (33)

1. Abbas, A., A. Lichtman, and J. Pober. 1994. Cellular and molecular immunology, 2nd ed. WB Saunders Co., Philadelphia, PA; p. 283.
2. Angiolillo, A.L., C. Sgadari, D.D. Taub, F. Liao, J.M. Farber, S. Maheshwari, H.K. Kleinman, G.H. Reaman, and G. Tosato. 1995. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182:155-162.
3. Asadullah, K., W. Sterry, K. Stephanek, D. Jasulaitis, M. Leupold, H. Audring, H.D. Volk, and W.D. Docke. 1998. IL-10 is a key cytokine in psoriasis. J. Clin. Invest. 101:783-794.
4. Ashack, R.J., M.L. Frost, and A.L. Norins. 1989. Papular pruritic eruption of demodex folliculitis in patients with the acquired immunodeficiency syndrome. J. Am. Acad. Dermatol. 21:306-307.
5. Baker, B., and L. Fry. 1992. The immunology of psoriasis. Br. J. Dermatol. 126:1-9.
6. Bason, M.M., T.G. Berger, and L.T. Nesbitt. 1993. Pruritic papular eruption of HIV-disease. Intl. J. Dermatol. 32:784-789.
7. Chehimi, J., X. Ma, S. Chouaib, A. Zyad, T. Nagashummugam, L. Wojcik, S. Chehimi, L. Nissim, and I. Frank. 1996. Differential production of interleukin 10 during human immunodeficiency virus infection. AIDS Res. Hum. Retrovir. 12:1141-1149.
8. Clerici, M., and G.M. Shearer. 1993. A TH1 → TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today. 14:107-111.
9. Duvic, M. 1987. Staphylococcal infections and the pruritus of AIDS-related complex. Arch. Dermatol. 123:1597.
10. Duvic, M. 1995. Human immunodeficiency virus and the skin: selected controversies. Cutaneous Skin Biology Symposium. J. Invest. Dermatol. 105:117S-121S.
11. Duvic, M., T.M. Johnson, R.P. Rapini, T. Freese, G. Brewton, and A. Rios. 1987. Acquired immunodeficiency syndrome-associated psoriasis and Reither's syndrome. Arch. Dermatol. 123:1622-1632.
12. Foreman KE, Friborg J, Kong W.P., C. Woffendin, P.J. Polverini, B.J. Nickoloff, and G.J. Nabel. 1997. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N. Engl. J. Med. 336:163-171.
13. Hardman, C.M., B.S. Baker, J. Lortan, J. Breuer, T. Surentheran, A. Powles, and L. Fry. 1997. Active psoriasis and profound CD4+ lymphocytopenia. Br. J. Dermatol. 136:930-932.
14. Hevia, O., F. Jimenez-Acosta, P.I. Ceballos, E.W. Gould, and N.S. Penneys. 1991. Pruritic papular eruption of the acquired immunodeficiency syndrome: a clinicopathologic study. J. Am. Acad. Dermatol. 25:231-235.
15. Johnson, T.M., M. Duvic, R.P. Rapini, and A. Rios. 1985. AIDS exacerbates psoriasis. N. Engl. J. Med. 313:1415.
16. Krueger, J.G., J.F. Krane, M. Carter, and A.B. Gottlieb. 1990. Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J. Invest. Dermatol. 94:135s-140s.
17. Kruskal, W.H., and W.A. Wallis. 1952. Use of ranks in one-criterion analysis on variance. J. Am. Stat. Assoc. 47:583-621.
18. Lewis, D.E., and W.J. Rickman. 1992. Methodology and quality control for flow cytometry. 164-173. Rose, R., E.C. DeMacario, (eds.): American Society for Microbiology manual of clinical laboratory immunology, 4th ed. Washington, D.C.
19. Makonkawkeyoon, S., R.N. Limson-Pobre, A.L. Moreira, V. Schauf, and G. Kaplan. 1993. Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:5974-5978.
20. Mann, H.B., and D.R. Whitney. 1947. On a test of whether one of two random variables is stochastically larger than the other. Annals Math. Stat. 18:50-60.
21. Margo, C.M., and A.N. Crowson. 1994. Eosinophilic pustular follicular reaction: a paradigm of immune dysregulation. Intl. J. Immunol. 33:172-178.
22. Moore, P., and Y. Chang. 1995. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N. Engl. J. Med. 322:1181-1185.
23. Moreira, A.L., E.P. Sampaio, A. Zmuidzinas, P. Frindt, K.A. Smith, and G. Kaplan. 1993. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med. 177:1675-1680.
24. Moritz, D.L., and C.A. Elmets. 1991. Eosinophilic pustular folliculitis. J. Am. Acad. Dermal. 24:903-907.
25. Nestle, F.O., L.A. Turka, and B.J. Nickoloff. 1994. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J. Clin. Invest. 94:202-209.
26. Odom, R., and T. Berger. 1990. Cutaneous manifestations of AIDS. Current Concepts. The Upjohn Company, Kalamazoo; pp. 17-23.
27. Osborn, L., S. Kunkel, and G.J. Nabe. 1989. Tumor necrosis and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc. Natl. Acad. Sci. USA 86:2336-2340.
28. Salazar-Gonzalez, J.F., O. Martinez-Maza, N. Aziz, J.A. Kolberg, T. Yeghiazarian, L.P. Shen, and J.L. Fahey. 1997. Relationship of plasma HIV-RNA levels and levels of TNF-alpha and immune activation products in HIV infection. Clin. Immunol. Immunopath. 84:36-45.
29. Silva, S.R., P.C. Viana, N.V. Lugon, M. Hoette, F. Ruzany, and J.R. Lugon. 1994. Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial. Nephron 67:270-273.
30. Smith, K.J., H.G. Skelton, W.D. James, D.M. Frissman, T.L. Barrett, P. Angritt, and G.P. Lupton. 1991. Papular eruption of human immunodeficiency virus disease. Am. J. Dermatopathol. 13:445-451.
31. Taub, D.D., T.J. Sayers, C.R. Carter, and J.R. Ortaldo. 1995. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:3877-3888.
32. Uthayakumar, S., R. Nandwani, T. Drinkwater, A.T. Nayagam, and C.R. Darley. 1997. The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression. Br. J. Dermatol. 137:595-598.
33. Visser J., A. van Boxel-Dezaire, D. Methorst, T. Brunt, E.R. de Kloet, and L. Nagelkerken. 1998. Differential regulation of interleukin-10 and IL-12 by glucocorticoids in vitro. Blood 91:4255-4264.